RecruitingPhase 1NCT05925036

Novel Cellular Therapy for the Treatment of Pain Associated With Chronic Pancreatitis


Sponsor

VA Office of Research and Development

Enrollment

40 participants

Start Date

Jan 1, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

The goal of this clinical trial is to test whether adult stem cells, called mesenchymal stem cells (MSCs) collected from the patient's bone marrow can help reduce pain caused by chronic pancreatitis and improve pancreatic function.


Eligibility

Min Age: 18 YearsMax Age: 75 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Mesenchymal stem cells and Placebo for people with chronic pain and chronic pancreatitis. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years to 75 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGMesenchymal stem cells

Autologous bone marrow derived MSCs

OTHERPlacebo

Controls


Locations(1)

Ralph H. Johnson VA Medical Center, Charleston, SC

Charleston, South Carolina, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05925036


Related Trials